Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis - Six years experiences on its effectiveness, toxicity, and acceptability

Kekkaku

Volumn 74, Issue 4, 1999, Pages 353-360

  Wada, Masako ^a   Yoshiyama, Takashi ^b   Ogata, Hideo ^b   Ito, Kunihiko ^b   Mizutani, Seiji ^b   Sugita, Hironobu ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NONE

Author keywords

6 month short course regimen; Diabetes Mellitus; Drug induced hepatotoxicity; Pyrazinamide; Relapse rate

Indexed keywords

AMINOTRANSFERASE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; CHEMOTHERAPY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; HUMAN; LIVER FUNCTION; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; LIVER DISEASES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PYRAZINAMIDE; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, PULMONARY;

EID: 0032909263     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sudre P, Dan GT, Kochi A. : Tuberculosis : A global overview of the situation today. Bull WHO. 1992 ; 70 : 149-159.
2. Dolin PJ, Raniglione MC, Kochi A, et al. : Estimated of future global tuberculosis morbidity and mortality. MMWR. 1993 ; 42 : 961-964.
3. Singapore Tuberculosis Service/British Medical Council : Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1979 ; 199 : 579-585.
4. Singapore Tuberculosis Service/British Medical Council : Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis : The results up to 30 months. Tubercle. 1981 ; 62 : 95-102.
5. Singapore Tuberculosis Service/British Medical Council : Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis : Am Rev Respir Dis. 1986 ; 133 : 779-783.
6. British Thoracic Association : A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report : Results during chemotherapy. Br J Dis Chest. 1981 ; 75 : 141-153.
7. British Thoracic Association : A controlled trial of six months chemotherapy in pulmonary tuberculosis. Final Report : Results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest. 1984 , 78 : 330-336,
8. Combs DL, O'Brien JR, and Gliter L : UHPHS tuberculosis short-course chemotherapy trial 21 : Effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med. 1990 ; 112 : 379-406.
9. Singh J, Arora A, Garg PK, et al. : Antituberculosis treatment-induced hepatotoxicity : role of predictive factors. Postgrad Med J. 1995 ; 71 : 359-362.
10. Durand F, Bernau J, Pesayre D, et al. : Deterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepathology. 1995 ; 21 : 929-932.
11. Mitchell I, Wenden J, Fitt S, Williams R : Anti-tuberculous therapy and acute liver failure. Lancet. 1995 ; 345 : 555-556.